Coronavirus (COVID-19) vaccine

Protect yourself, get vaccinated!

Protect yourself against COVID-19 by layering protective measures including continuing to wear a well-fitted mask in indoor public settings, practising physical distancing, daily symptom screening, staying home when ill, and staying up to date with all recommended COVID-19 vaccinations.

Individuals are up to date with their COVID-19 vaccines when they have received all recommended COVID-19 vaccine doses, including any booster dose(s) when eligible. It remains important for everyone to complete their primary series if they have not already and get any booster dose(s) as soon as possible.

Individuals seeking a COVID-19 vaccine, can book an appointment at a Public Health clinic, contact their health care provider, a participating pharmacy (Government of Ontario), or health centre.

Vaccination clinics for COVID-19

Public Health Sudbury & Districts hosts mobile, pop-up, and walk-in clinics. For details on upcoming vaccination clinics and eligibility, visit our vaccination clinics page.

COVID-19 vaccine eligibility

Get vaccinated and stay up to date! It is highly encouraged you receive all recommended COVID-19 vaccine doses, including any booster doses when eligible to stay up to date and to build long-term protection against COVID-19. Visit our vaccination eligibility page.

Doses administered

Public Health Sudbury & Districts reports COVID-19 vaccination data Wednesday’s at 4 p.m.

COVID-19 vaccines

mRNA COVID-19 vaccine

All Public Health clinics offer mRNA vaccine brands—either Moderna Spikevax or Pfizer-BioNTech Comirnaty (pediatric and adult doses). A reminder that for those aged 30 years and older, the adult dose of Pfizer-BioNTech Comirnaty and Moderna Spikevax vaccines can be safely interchanged. Individuals 12 to 29 will be offered an adult dose of the Pfizer-BioNTech Comirnaty; however, anyone 12 to 29 years old who wishes to receive Moderna Spikevax may do so with informed consent. The Moderna Spikevax (50mcg) vaccine may also be considered for moderately to severely immunocompromised children 6 to 11 years of age (ModernaTX, Inc., PDF).

Non-mRNA COVID-19 vaccines

Public Health keeps a limited supply of the single-dose Janssen (Johnson & Johnson) vaccine and the Novavax Nuvaxovid vaccine.

Eligible individuals who are unable to receive a mRNA vaccine, who have not yet received an mRNA vaccine, and who are over the age of 18 years old may request an appointment to receive a non-mRNA COVID-19 vaccine. Individuals must be informed of the risks associated with non-mRNA vaccines.

Individuals must be informed of the risks associated with non-mRNA vaccines and must provide informed consent for both Janssen (Johnson &Johnson) vaccine and Novavax Nuvaxovid vaccine.

Learn more about the Health Canada approved COVID-19 vaccines.

Report your COVID-19 vaccination(s) in the provincial database (COVaxON)

If your COVID-19 vaccination records are not in the provincial online database, we encourage you to submit your proof of vaccinations to help public health agencies monitor vaccine coverage.

If you have received a COVID-19 vaccination outside of Ontario or Canada  you will need to submit your proof of vaccination to have your COVID-19 immunization record documented in the provincial system (COVaxON) to obtain an enhanced vaccination certificate with QR code.

COVID-19 vaccine Resources

Public Health Sudbury & Districts has several free downloadable resources. Visit our COVID-19 vaccine resource page and our child and youth vaccine toolkit.

COVID-19 vaccine campaigns

Learn more about Public Health Sudbury & Districts vaccination campaigns:

Frequently asked questions

Do you have questions about the COVID-19 vaccine? Check out our vaccine FAQ section to find out about safety and efficacy of the vaccines, who is eligible for vaccination, and more.

To learn even more, visit our COVID-19 vaccine resources page, or contact Public Health by calling 705.522.9200 (toll free: 1.866.522.9200).

If you are a health care provider read our Advisory Alerts for more information.


This item was last modified on May 13, 2022